I. - Basic information

I.1 - Surname

Kráľová

I.2 - Name

Eva

I.3 - Degrees

PharmDr. PhD.

I.4 - Year of birth

1982

I.5 - Name of the workplace

Faculty of Pharmacy UK Bratislava

I.6 - Address of the workplace

Depararment of Pharmacology and toxicology

I.7 - Position

Assistant professors:

I.8 - E-mail address

kralova5@uniba.sk

I.9 - Hyperlink to the entry of a person in the Register of university staff

https://www.portalvs.sk/regzam/detail/3733?do=filterForm-submit&surname=Kr%C3%A1%C4%BEov%C3%A1&university=701000000&faculty=701060000&sort=surname&employment_state=no&filter=Vyh%C4%BEada%C5%A5

I.10 - Name of the study field in which a person works at the university

pharmacology

II. - Higher education and further qualification growth

II.1 - First degree of higher education

II.2 - Second degree of higher education

II.a - Name of the university or institution

Faculty of Pharmacy UC Bratislava

II.b - Year

2005

II.c - Study field and programme

Pharmacy

II.3 - Third degree of higher education

II.a - Name of the university or institution

Jessenius Faculty of Medicine, CU Bratislava

II.b - Year

2010

II.c - Study field and programme

Pharmacology

II.4 - Associate professor

II.5 - Professor

II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position	III.b - Institution	III.c - Duration
Assistant professors:	Faculty of Pharmacy CU Bratislava	2008-

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other	IV.b - Name of the institution	IV.c - Year
Completion of the program Protection of animals used for scientific purposes, Module: implementation of procedures and projects	Veterinary Training Institute	2015,2019,2023
Workshops on Internationalizing the Curriculum	Comenius University Bratislava in cooperation with Mestenhauser Institute for International Collaboration	2025

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes

V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year

V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year

V.4 - Overview of supervised final theses

V.4.1 - Number of currently supervised theses

V.4.b - Diploma (second degree)

V.4.c - Dissertation (third degree)

V.4.2 - Number of defended theses

V.4.a - Bachelor's (first degree)

V.4.b - Diploma (second degree)

V.5 - Overview of other courses taught in the current academic year according to study programmes

V.5.a - Name of the course	V.5.b - Study programme	V.5.c - Degree
Human anatomy and physiology	Pharmacy	1 and 2
Pathology	Pharmacy	1 and 2
Human anatomy and physiology	Medical and diagnostic devices	1
Pathology	Medical and diagnostic devices	1
Clinical Pharmacology and Pharmacotherapy	Pharmacy	1
Clinical Pharmacy and Pharmacoterapy	Pharmacy	1

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations

VI.1.1 - Number of the research/artistic/other outputs

VI.1.a - Overall

128

VI.1.b - Over the last six years

VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.3 - Number of citations corresponding to the research/artistic/other outputs

VI.1.a - Overall

217

VI.1.b - Over the last six years

140

VI.1.4 - Number of citations registered in the Web of Science or Scopus databases

VI.1.a - Overall

201

VI.1.b - Over the last six years

VI.1.5 - Number of invited lectures at the international, national level

VI.2 - The most significant research/artistic/other outputs

Činaková, Aneta - Vavrincová-Yaghi, Diana - Křenek, Peter - Klimas, Ján - Kráľová, Eva Combination of dapagliflozin and pioglitazone lacks superiority against monotherapy in streptozotocin-induced nephropathy In: Scientific reports. Roč. 15, č. 1 (2025), 1-11

Kráľova, Eva- Hadová, Katarína- Činákova Aneta, Křenek, Peter, Klimas, Ján: Pioglitazone Alters Ace/Ace 2 Balance to Favour Ace2 Independently Of Glycaemia Levels in Diabetic Rat Heart In: Die Pharmazie, 2023, 78(8), pp. 122–127

Kráľová, Eva - Dóka, Gabriel - Bies Piváčková, Lenka - Šrankova, Jasna - Mikuš Kuracinová, Kristína - Janega, Pavol- Babál, Pavel - Klimas, Ján - Křenek, Peter : L-arginine attenuates cardiac dysfunction, but further down-regulates alpha-myosin heavy chain expression in isoproterenol-induced cardiomyopathy In: Basic & Clinical Pharmacology & Toxicology. - Vol. 117, No. 4 (2015), s. 251-260. - ISSN 1742-7835

Nichtová, Zuzana - Novotová, Marta - Kráľová, Eva - Stankovičová, Tatiana: Morphological and functional characteristics of models of experimental myocardial injury induced by isoproterenol In: General Physiology and Biophysics. - Vol. 31, No. 2 (2012), s. 141-151. - ISSN 0231-5882

Kráľová, Eva - Marušáková, Margaréta - Hadová, Katarína - Křenek, Peter - Klimas, Ján Dapagliflozin elevates plasma high-density lipoprotein levels andinfluences visceral fat gene expression in streptozotocin-induced diabetes mellitus In: Journal of Pharmacy and Pharmacology [elektronický dokument]. - Roč. 73, č. 6 (2021), s. 778-784 [print]. - ISSN (print) 0022-3573

VI.3 - The most significant research/artistic/other outputs over the last six years

Čináková Aneta-Křenek, Peter - Klimas, Ján- Kráľová, Eva:Adding SGLT2 Cotransporter Inhibitor to PPARy Activator Does Not Provide an Additive Effect in Management of Diabetes-Induced Vascular Dysfunction In: Pharmacology, 2023, 108(6), pp. 565–575

Hadová, Katarína - Mesárošová, Lucia- Kráľová, Eva - Dóka, Gabriel - Křenek, Peter - Klimas, Ján : The tyrosine kinase inhibitor crizotinib influencesblood glucose and mRNA expression of GLUT4 and PPARs in the heart of rats with experimental diabetes In: Canadian Journal of Physiology and Pharmacology [elektronický dokument]. - Roč. 99, č. 6 (2021), s. 635-643 [print]. - ISSN (print) 0008-4212

Hadová, Katarína - Kráľová, Eva - Dóka, Gabriel - Bies Piváčková, Lenka - Kmecová, Zuzana - Křenek, Peter - Klimas, Ján: Isolated downregulation of HCN2 in ventricles of rats with streptozotocin-induced diabetic cardiomyopathy In: BMC Cardiovascular Disorders [elektronický dokument]. - Roč. 21, č. 1 (2021), s. [1-11], art.no. 118 [online]. - ISSN (online) 1471-2261

VI.4 - The most significant citations corresponding to the research/artistic/other outputs

2024 CHN - Li, Wenjun - Guan, Yexia - Shi, Lin - Chen, Yang - Huang, Huang - Zhen, Haiyin - Wu, Ping - Wang, Chao - Wu, Qian - Li, Wei. Identification of angiotensin-converting enzyme inhibitory peptides from peanut meal (Arachis hypogaea Linn) fermented by Lactobacillus pentosus using MALDI-TOF–MS and LC–MS/MS In: Food Frontiers. Peking: John Wiley & Sons, 2024, Roč. 5, č. 2, s. 820-8322

2023 Qian, L.-L., Liu, X.-Y., Li, X.-Y., Yang, F., Wang, R.-X.:Effects of Electrical Remodeling on Atrial Fibrillation in Diabetes Mellitus . Rev. Cardiovasc. Med.2023, 24(1), 156

2023 CHE - Gonikman, Daniel - Kustovs, Dmitrijs. Antidiabetic Drug Efficacy in Reduction of Mortality during the COVID-19 Pandemic [elektronický dokument]. DOI 10.3390/medicina59101810 In: Medicina. Basel: Multidisciplinary Digital Publishing Institute, 2023, Roč. 59, č. 10, art. no. 1810,

2022 Theofilis P, Sagris M, Oikonomou E, Antonopoulos AS, Siasos G, Tsioufis K, Tousoulis D.:The impact of SGLT2 inhibitors on inflammation: A systematic review and meta-analysis of studies in rodents, Int Immunopharmacol. 2022 Oct;111:109080.

2021 Werhahn, S.M. - Kreusser, J.S. - Hagenmuller, M. - Beckendorf, J. - Diemert, N. - Hoffmann, S. - Schultz, J.H. - Backs, J. - Dewenter, M.: PLoS ONE, Vol. 16, No. 6, 2021, art. no. e0248933

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

VEGA 1/0004/18 - responsible researcher, Prevention of cardiorenal syndrome development in an experimental model of diabetes mellitus by modulation of SGLT2 transporter and PPAR gamma receptor

APVV-19-0458 -co-investigator, Convergence of serotonin and growth factors associated with pulmonary hypertension in modulation of right ventricular function and failure

APVV 15-0685 -co-researcher, Teranostic potential of alternative RAS components in modulation of right ventricular function and dysfunction

VEGA 1/0304/17 -co-researcher, The role of HCN channels in the development of diabetic cardiomyopathy and related changes in myocardial electrogenesis

VEGA 1/0195/20- co-researcher, The role of HCN channels in the development of diabetic cardiomyopathy and related changes in myocardial electrogenesis

APVV-19-0154- co-reseacher, Study of biological effects of H2S/NO/selenium products and molecular mechanisms of their actions

VEGA- 2/0091/21- co- reseacher- Significance of H2S interaction products with S-nitrosoglutathione / selenium derivatives in the regulation of cardiovascular hemodynamics and cardiac mitochondrial functions

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position	VII.b - Name of the institution, board	VII.c - Duration
Staff Teaching mobility (STA)	Faculty of Pharmacy, Ljubljana, Aškerčeva cesta 7, p.p. 311, SI-1000 Ljubljana	20.11.2023 -24.11.2023

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update

2025-01-24

Name and surname:	PharmDr. Eva Kráľová, PhD.
Document type:	Research/art/teacher profile of a person
The name of the university:	Comenius University Bratislava
The seat of the university:	Šafárikovo námestie 6, 818 06 Bratislava